4.7 Article

Progressive Development of Cefiderocol Resistance in Escherichia coli During Therapy is Associated With an Increase in blaNDM-5 Copy Number and Gene Expression

Related references

Note: Only part of the references are listed.
Article Immunology

Rapid Development of Cefiderocol Resistance in Carbapenem-resistant Enterobacter cloacae During Therapy Is Associated With Heterogeneous Mutations in the Catecholate Siderophore Receptor cirA

Sabrina Klein et al.

Summary: This report presents a case of resistance development to cefiderocol in a patient with intra-abdominal and bloodstream infections caused by carbapenemase-producing Enterobacter cloacae. Whole genome sequencing revealed heterogeneous mutations in the cirA gene, which encodes a siderophore receptor, contributing to phenotypic resistance to cefiderocol.

CLINICAL INFECTIOUS DISEASES (2022)

Article Infectious Diseases

Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial

Matteo Bassetti et al.

Summary: The study assessed the efficacy and safety of cefiderocol versus best available therapy in the treatment of patients with carbapenem-resistant Gram-negative infections. Cefiderocol showed similar clinical and microbiological efficacy to best available therapy in this heterogeneous patient population with infections caused by carbapenem-resistant Gram-negative bacteria, suggesting it as an option for the treatment of carbapenem-resistant infections in patients with limited treatment options.

LANCET INFECTIOUS DISEASES (2021)

Article Immunology

Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa)

Pranita D. Tamma et al.

Summary: This guidance document provides recommendations for the treatment of antimicrobial-resistant infections commonly encountered in US hospitals, focusing on ESBL-E, CRE, and DTR-P. aeruginosa. It includes preferred and alternative treatment recommendations, discussion on empiric treatment selection and management considerations, and will be periodically updated. The current version is as of 17 September 2020, with plans to expand recommendations to include other problematic gram-negative pathogens in future versions.

CLINICAL INFECTIOUS DISEASES (2021)

Article Microbiology

New Perspectives on Antimicrobial Agents: Cefiderocol

Erin K. McCreary et al.

Summary: Carbapenem resistance in bacteria is a concerning issue, leading to the development of new antibiotics like cefiderocol. However, conflicting clinical data have left infectious diseases specialists unsure of when to prescribe this novel agent. Research focuses on cefiderocol's role in managing specific pathogens, with summaries of preclinical, clinical trial, and postmarketing data for various organisms to help guide clinical therapeutic decisions.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)

Letter Public, Environmental & Occupational Health

Risk Factors for Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae Carriage Upon Pediatric Intensive Care Unit Admission

David X. Li et al.

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2018)

Article Infectious Diseases

Activity of the novel siderophore cephalosporin cefiderocol against multidrug-resistant Gram-negative pathogens

J. Dobias et al.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2017)

Article Biotechnology & Applied Microbiology

Knocking out analysis of tryptophan permeases in Escherichia coli for improving L-tryptophan production

Pengfei Gu et al.

APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2013)

Editorial Material Biochemistry & Molecular Biology

MarR family transcription factors

Anne Grove

CURRENT BIOLOGY (2013)

Article Infectious Diseases

The tetA gene decreases tigecycline sensitivity of Salmonella enterica isolates

Tatsuya Akiyama et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2013)

Article Biochemistry & Molecular Biology

Remodelling of the Escherichia coli outer membrane by two small regulatory RNAs

M Guillier et al.

MOLECULAR MICROBIOLOGY (2006)